Literature DB >> 16227268

Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B.

Itsuki Hamamoto1, Yorihiro Nishimura, Toru Okamoto, Hideki Aizaki, Minyi Liu, Yoshio Mori, Takayuki Abe, Tetsuro Suzuki, Michael M C Lai, Tatsuo Miyamura, Kohji Moriishi, Yoshiharu Matsuura.   

Abstract

The hepatitis C virus (HCV) nonstructural protein (NS) 5A is a phosphoprotein that associates with various cellular proteins and participates in the replication of the HCV genome. Human vesicle-associated membrane protein-associated protein (VAP) subtype A (VAP-A) is known to be a host factor essential for HCV replication by binding to both NS5A and NS5B. To obtain more information on the NS5A protein in HCV replication, we screened human brain and liver libraries by a yeast two-hybrid system using NS5A as bait and identified VAP-B as an NS5A-binding protein. Immunoprecipitation and mutation analyses revealed that VAP-B binds to both NS5A and NS5B in mammalian cells and forms homo- and heterodimers with VAP-A. VAP-A interacts with VAP-B through the transmembrane domain. NS5A interacts with the coiled-coil domain of VAP-B via 70 residues in the N-terminal and 341 to 344 amino acids in the C-terminal polyproline cluster region. NS5A was colocalized with VAP-B in the endoplasmic reticulum and Golgi apparatus. The specific antibody to VAP-B suppressed HCV RNA replication in a cell-free assay. Overexpression of VAP-B, but not of a mutant lacking its transmembrane domain, enhanced the expression of NS5A and NS5B and the replication of HCV RNA in Huh-7 cells harboring a subgenomic replicon. In the HCV replicon cells, the knockdown of endogenous VAP-B by small interfering RNA decreased expression of NS5B, but not of NS5A. These results suggest that VAP-B, in addition to VAP-A, plays an important role in the replication of the HCV genome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227268      PMCID: PMC1262604          DOI: 10.1128/JVI.79.21.13473-13482.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  VAP-A binds promiscuously to both v- and tSNAREs.

Authors:  M L Weir; H Xie; A Klip; W S Trimble
Journal:  Biochem Biophys Res Commun       Date:  2001-08-24       Impact factor: 3.575

2.  Mouse VAP33 is associated with the endoplasmic reticulum and microtubules.

Authors:  P A Skehel; R Fabian-Fine; E R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.

Authors:  V Christopher; N Scolding; R T Przemioslo
Journal:  J Neurol       Date:  2005-03-08       Impact factor: 4.849

4.  A functional role for VAP-33 in insulin-stimulated GLUT4 traffic.

Authors:  L J Foster; M L Weir; D Y Lim; Z Liu; W S Trimble; A Klip
Journal:  Traffic       Date:  2000-06       Impact factor: 6.215

Review 5.  The non-structural 5A protein of hepatitis C virus.

Authors:  J M Pawlotsky; G Germanidis
Journal:  J Viral Hepat       Date:  1999-09       Impact factor: 3.728

6.  Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner.

Authors:  M Majumder; A K Ghosh; R Steele; R Ray; R B Ray
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.

Authors:  T Pietschmann; V Lohmann; G Rutter; K Kurpanek; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3.

Authors:  K M Chung; J Lee; J E Kim; O K Song; S Cho; J Lim; M Seedorf; B Hahm; S K Jang
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein.

Authors:  P Neddermann; A Clementi; R De Francesco
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

10.  Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein.

Authors:  H Tu; L Gao; S T Shi; D R Taylor; T Yang; A K Mircheff; Y Wen; A E Gorbalenya; S B Hwang; M M Lai
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

View more
  87 in total

1.  Poly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5' untranslated region and directs HCV RNA replication through circularizing the viral genome.

Authors:  Linya Wang; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Viral infection: Moving through complex and dynamic cell-membrane structures.

Authors:  Jonathan Barroso-González; Laura García-Expósito; Julià Blanco; Agustín Valenzuela-Fernández; Isabel Puigdomènech; Laura de Armas-Rillo; José-David Machado
Journal:  Commun Integr Biol       Date:  2011-07-01

Review 3.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

Review 4.  New therapeutic opportunities for hepatitis C based on small RNA.

Authors:  Qiu-Wei Pan; Scot D Henry; Bob J Scholte; Hugo W Tilanus; Harry L A Janssen; Luc J W van der Laan
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

5.  Japanese encephalitis virus core protein inhibits stress granule formation through an interaction with Caprin-1 and facilitates viral propagation.

Authors:  Hiroshi Katoh; Toru Okamoto; Takasuke Fukuhara; Hiroto Kambara; Eiji Morita; Yoshio Mori; Wataru Kamitani; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

6.  Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A.

Authors:  Chao-Kuen Lai; King-Song Jeng; Keigo Machida; Michael M C Lai
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.

Authors:  Feng Yang; Jason M Robotham; Heather B Nelson; Andre Irsigler; Rachael Kenworthy; Hengli Tang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

8.  Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning.

Authors:  Nuno Rocha; Coenraad Kuijl; Rik van der Kant; Lennert Janssen; Diane Houben; Hans Janssen; Wilbert Zwart; Jacques Neefjes
Journal:  J Cell Biol       Date:  2009-06-29       Impact factor: 10.539

9.  Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.

Authors:  Yuuki Kaname; Hideki Tani; Chikako Kataoka; Mai Shiokawa; Shuhei Taguwa; Takayuki Abe; Kohji Moriishi; Taroh Kinoshita; Yoshiharu Matsuura
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

Review 10.  Towards a small animal model for hepatitis C.

Authors:  Alexander Ploss; Charles M Rice
Journal:  EMBO Rep       Date:  2009-10-16       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.